Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Share-based Compensation Growth (1y) (2021)

Immuron (IMRN) Share-based Compensation Growth (1y) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 71.86%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -3.46%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -7.69%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -8.89%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -22.43%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 11.71%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -4.01%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Immuron 6.75 Mn 6.73 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 565.64%